OTC, supplements & other. Every registered pack in the UAE with published prices, agents and manufacturers; the price spread between brands; the same medicine in India, the US and the EU; and same‑class alternatives.
Unit price to public, same form and strength, registered brands only. Green = cheapest. The spread is the gap a class‑level tender or formulary switch can usually close.
India: India brand MRP (median of 7) ₹75.87 ($0.903) per tablet at 200mg. US prices are not published by FDA; EU prices are national. Ask us for a landed‑cost benchmark.
₹63.00–2,433.96 per unit across 7 priced packs. MRP as printed on pack (indicative, open dataset 2024); combinations listed after single‑ingredient brands. Showing 7 of 7.
| Brand | Manufacturer | Strength | Pack | MRP ₹ | ₹ / unit |
|---|---|---|---|---|---|
| Sorepto 200mg Tablet | Lupin Ltd | 200mg | bottle of 30 tablets | ₹1,985.00 | ₹66.17 |
| Soranib Tablet | Cipla Ltd | 200mg | strip of 30 tablets | ₹2,276.01 | ₹75.87 |
| Adtrinib 200mg Tablet | Adley Formulations | 200mg | bottle of 30 tablets | ₹2,350.00 | ₹78.33 |
| Shilfenib 200mg Tablet | Shilpa Medicare Ltd | 200mg | bottle of 120 tablets | ₹7,560.00 | ₹63.00 |
| Sorafenat 200mg Tablet | Natco Pharma Ltd | 200mg | bottle of 120 tablets | ₹8,880.00 | ₹74.00 |
| Mapsonib 200mg Tablet | AMPS Biotech Pvt Ltd | 200mg | bottle of 30 tablets | ₹11,850.00 | ₹395.00 |
| Nexavar 200mg Tablet | Bayer Zydus Pharma Pvt Ltd | 200mg | bottle of 60 tablets | ₹146,037.50 | ₹2,433.96 |
Not yet classified.
None are Active on the UAE register at this release.
No published UAE price at this release.
No matching‑strength India reference price is available for a per‑unit comparison.
See the register tab.
Hospitals, pharmacies and distributors anywhere: tell us what you need and the Consulting Wallah Network returns comparable quotes from verified suppliers. No fee for buyers.
Data: DoH Abu Dhabi Shafafiya drug list (2 Nov 2026); FDA NDC Directory and Orange Book (Sept–Nov 2026); NPPA and PMBI Jan Aushadhi (Nov 2026); EMA (Nov 2026); WHO ATC/DDD 2026; Consulting Wallah class repository. For information only; verify with the regulator before purchase or dispensing. No prescribing advice. © Consulting Wallah — CC BY‑NC‑ND; bulk extraction not permitted.